Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
11/2009
11/05/2009US20090275664 Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
11/05/2009US20090275565 Substituted aralkyl derivatives
11/05/2009CA2722818A1 Preparation of 1,7´-dimethyl-2´-propyl-2,5´-bi-1h-benzimidazole
11/04/2009EP2113954A1 Organic electroluminescent device
11/04/2009EP2113031A1 Optically active, heteroaromatic beta-hydroxy esters, processes for their preparation from beta-keto esters and processes for the preparation of these beta-keto esters
11/04/2009EP1734038B1 Nitrogenous heterocycle derivative and organic electroluminescent element employing the same
11/04/2009EP1432700B1 Spiro-hydantoin compounds useful as anti-inflammatory agents
11/03/2009US7612211 TRPV1 ion channel mediated disease; chronic or acute pain, inflammatory pain, burning pain or post-operative pain; 2-[2-(4-trifluoromethyl-phenoxymethyl)-1H-benzoimidazol-5-yl]-benzenesulfonamide
11/03/2009US7612095 Polymorph of 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazole-2-yl]-1-piperidinyl]ethyl]-αα-dimethyl-benzeneacetic acid
10/2009
10/29/2009WO2009131065A1 Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009WO2009130679A1 Benzimidazole derivatives as calcium channel blockers
10/29/2009WO2009129625A1 Novel substituted heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
10/29/2009WO2009035951A3 Soluble epoxide hydrolase inhibitors
10/29/2009US20090270613 5-Fluoro-4-methyl-2-{2-[4-(4-methyl-piperazin-1-yl)-butoxy]-pyridin-4-yl}-1H-benzoimidazole; leukocyte recruitment inhibition, modulating H4 receptor, and treating conditions such as inflammation
10/29/2009US20090270611 Benzoimidazole compounds
10/29/2009US20090270473 Dual-acting antihypertensive agents
10/29/2009US20090270468 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
10/29/2009US20090270372 Melanocortin receptor MC4 modulators; obesity, sexual disorders, anxiolytic agents, analgesics, antidepressants; 6-(aminomethyl)-2-aminobenzimidazole derivatives
10/29/2009US20090270366 Benzoimidazole compounds
10/29/2009US20090270365 such as N-(2,4-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-2-(piperidin-1-ylmethyl)biphenyl-4-carboxamide, having vanilloid receptor 1 antagonistic activity, used as analgesics
10/29/2009CA2722258A1 N-acylthiourea and n-acylurea inhibitors of the hedgehog protein signalling pathway
10/29/2009CA2722075A1 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009CA2722067A1 Benzimidazole derivatives as calcium channel blockers
10/29/2009CA2720654A1 Novel substituted heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
10/27/2009US7608723 Indole and benzimidazole derivatives
10/22/2009WO2009129335A2 Selective inhibitors of histone deacetylase
10/22/2009WO2009128521A1 Cysteine protease inhibitor
10/22/2009WO2009084974A8 1,3-dialkyl-benzimidazole halogenides exhibiting regeneration, anti-inflammatory and antimicrobial activity
10/22/2009US20090264653 Useful indole compounds
10/22/2009US20090264647 Benzoimidazole compounds
10/22/2009US20090264646 Benzoimidazole compounds
10/22/2009US20090264645 Benzoimidazole compounds
10/22/2009US20090264488 Novel solid forms of bendamustine hydrochloride
10/22/2009US20090264424 Vanilloid receptor ligands and their use in treatments
10/22/2009US20090264414 Amide Derivatives and Pharmaceutical Use Thereof
10/22/2009CA2721218A1 Selective inhibitors of histone deacetylase
10/21/2009EP2110412A2 Nanosized particles of benzimidazolone pigments
10/21/2009CN101560158A Novel organic electroluminescent compounds and organic electroluminescent device using the same
10/21/2009CN100551914C Chemical synthesis of albendazole-sulphone
10/21/2009CN100551913C Chemical synthesis of albendazole-2-amino-sulphone
10/21/2009CN100551532C Method for preparing bisphenol catalysts and bisphenols
10/20/2009CA2585898C Use of (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4-thaizolyl)methyl)amino)-carbonyl)valinyl)amino)-2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane in combination with another protease inhibitor for treating hiv infection
10/20/2009CA2407371C Quinazoline derivatives for the treatment of tumours
10/20/2009CA2336909C Thiobenzimidazole derivatives which are useful as inhibitors of human chymase activity
10/15/2009WO2009126947A2 Heteroaryl-substituted bicyclic smac mimetics and the uses thereof
10/15/2009WO2009124627A1 Fluorine derivatives for organic electroluminescence devices
10/15/2009US20090258999 Silicon-urea-azolides, their preparation and use in the preparation of silicones with isocyanate terminal groups
10/15/2009US20090258909 Novel Benzimidazole Derivatives Useful as Selective Androgen Receptor Modulators (SARMS)
10/15/2009US20090258868 Heterocyclic aspartyl protease inhibitors
10/15/2009CA2725398A1 Heteroaryl-substituted bicyclic smac mimetics and the uses thereof
10/14/2009EP1720829B1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
10/14/2009CN101558068A Phenylacetamides useful as protein kinase inhibitors
10/14/2009CN101555231A Method for preparing triclabendazole
10/14/2009CN101555230A Synthesizing method of aromatic ring ureas loop-coil medicament template
10/14/2009CN100549014C Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
10/14/2009CN100549011C Novel imidazopyridines as cyclin dependent kinase inhibitors
10/14/2009CN100548990C Processes for preparing benzo[b]thiophene derivatives
10/13/2009US7601859 Organometallic complexes
10/13/2009US7601750 Hydroxyalkylindole derivatives as anticancer agents; methyl [3-hydroxymethyl-2-(1-pentyl)-1-(2-phenylethyl)-5-methyl]indole-6-carboxylate, for example
10/13/2009US7601745 Nuclear factor kappa beta (NF-kB) inhibitors such as [4-(1H-Indol-3-yl)-piperidin-1-yl]-{2-[1-(pyrazine-2-carbonyl)-piperidin-4-yl]-thiazol-4-yl}-methanone
10/08/2009WO2009123569A1 Method for treating neurological disorders with imidazolium and imidazolinium compounds
10/08/2009WO2009123483A1 Process for preparation of telmisartan
10/08/2009WO2009122034A2 Novel hsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
10/08/2009US20090253762 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
10/08/2009US20090253707 Heteroannelated anthraquinone derivatives and the synthesis method thereof
10/08/2009US20090253656 Bcrp/abcg2 inhibitor
10/08/2009CA2718488A1 Novel dhsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
10/07/2009EP2107052A1 Novel n-(2-aminophenyl)benzamide derivative having an urea structure
10/07/2009CN101553468A Organic compounds
10/07/2009CN101550166A Electric phosphorescent alpha-pinene derivant metal complex
10/07/2009CN101550107A Method for preparing telmisartan
10/07/2009CN101550085A Novel organic electroluminescent compounds and organic electroluminescent device using the same
10/07/2009CN100546981C Chemical synthesis method of 2-chlorin benzimidazole
10/07/2009CN100546980C Benzimidazole derivates: preparation and pharmaceutical applications
10/07/2009CN100546977C New compounds for the inhibition of rotamases and use thereof
10/06/2009US7598418 Naphthalene-1-(sulfonamide or carboxamide) derivatives; e.g. N-Benzyl-5-{[(4-methylphenyl)sulfonyl]oxy}naphthalene-1-sulfonamide; protein kinase inhibitors sensitize cancer cells to radiotherapy or anticancer agents; side effect reduction
10/06/2009US7598393 Sulfonyl benzimidazole derivatives
10/06/2009US7598389 Silylated carboxamides
10/06/2009US7598266 Fused heterocyclic derivatives as PPAR modulators
10/06/2009CA2427617C Medicinal compositions for concomitant use as anticancer agent
10/01/2009WO2009120874A2 INHIBITORS OF ANTIGEN RECEPTOR-INDUCED NF-кB ACTIVATION
10/01/2009WO2009119776A1 Fused heterocyclic derivative and use thereof
10/01/2009WO2009118562A1 Pharmaceutical composition 271
10/01/2009WO2009118292A1 Arylsulfonamide-based matrix metalloprotease inhibitors
10/01/2009WO2009080555A3 Carboxyl- or hydroxyl- substituted benzimidazole derivatives
10/01/2009WO2009074300A3 Hedgehog pathway antagonists and therapeutic applications thereof
10/01/2009US20090247520 INHIBITORS OF ANTIGEN RECEPTOR-INDUCED NF-kappa B ACTIVATION
10/01/2009US20090247508 Benzoimidazole Compounds
10/01/2009US20090247506 Antibacterial agents
10/01/2009CA2719767A1 Inhibitors of antigen receptor-induced nf-.kappa.b activation
10/01/2009CA2719457A1 Arylsulfonamide-based matrix metalloprotease inhibitors
10/01/2009CA2718653A1 Pharmaceutical composition 271
09/2009
09/30/2009EP1553089B1 Antagonist of melanin-concentrating hormone receptor comprising benzimidazole derivative as active ingredient
09/30/2009CN101544608A 5-(2-(trifluoromethyl)-2,3-dihydro-1H-benzoglioxaline) methyl valerate and synthesis method thereof
09/29/2009US7595406 e.g. 2-{4-[1-(cyclohexylmethylamino)ethyl]phenyl}-1H-benzimidazole-4-carboxamide; poly-ADP-ribose polymerase inhibitor; antiinflammatory, anticarcinogenic, antidiabetic, antiischemic agent; neurodegenerative diseases
09/29/2009US7595399 Tyrosine derivatives
09/29/2009US7595343 Inhibitors of histone deacetylase
09/29/2009CA2484460C Polymorph of 4-[2-[4-[1-(2-ethoxyethyl)-1h-benzimidazole-2-yl]-1-piperidinyl]ethyl]-.alpha..alpha. dimethyl-benzeneacetic acid
09/29/2009CA2255171C 1,3,8-triaza-spiro[4,5]decan-4-on derivatives
09/24/2009WO2009117489A1 Dexlansoprazole process and polymorphs
1 ... 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 ... 154